A detailed history of Pathstone Family Office, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Pathstone Family Office, LLC holds 70,782 shares of MDT stock, worth $5.46 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
70,782
Previous 33,470 111.48%
Holding current value
$5.46 Million
Previous $2.95 Million 88.13%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$78.22 - $90.4 $2.92 Million - $3.37 Million
37,312 Added 111.48%
70,782 $5.55 Million
Q2 2023

Jan 12, 2024

SELL
$79.47 - $91.38 $2.86 Million - $3.28 Million
-35,939 Reduced 50.77%
34,843 $3.07 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $44,026 - $50,624
-554 Reduced 1.63%
33,470 $2.95 Million
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $189,344 - $216,147
-2,468 Reduced 6.76%
34,024 $2.74 Million
Q4 2022

Oct 23, 2023

BUY
$76.18 - $87.74 $27,424 - $31,586
360 Added 1.0%
36,492 $2.84 Million
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $611,953 - $704,815
-8,033 Reduced 18.04%
36,492 $2.84 Million
Q3 2022

Oct 23, 2023

BUY
$80.75 - $95.31 $928,059 - $1.1 Million
11,493 Added 46.65%
36,132 $2.92 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $894,629 - $1.06 Million
11,079 Added 33.13%
44,525 $3.63 Million
Q2 2022

Oct 23, 2023

SELL
$87.4 - $113.09 $771,829 - $998,697
-8,831 Reduced 26.38%
24,639 $2.21 Million
Q2 2022

Aug 15, 2022

BUY
$87.4 - $113.09 $1.13 Million - $1.46 Million
12,934 Added 63.06%
33,446 $3.01 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $158,212 - $176,773
-1,573 Reduced 7.12%
20,512 $2.3 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $151,982 - $195,074
1,527 Added 7.43%
22,085 $2.29 Million
Q3 2021

Nov 16, 2021

BUY
$122.75 - $135.17 $1.23 Million - $1.36 Million
10,060 Added 95.83%
20,558 $2.58 Million
Q2 2021

Aug 31, 2021

BUY
$118.19 - $131.5 $390,145 - $434,081
3,301 Added 45.87%
10,498 $1.31 Million
Q1 2021

May 14, 2021

BUY
$111.18 - $119.74 $265,831 - $286,298
2,391 Added 49.75%
7,197 $853,000
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $458,800 - $534,392
4,562 Added 1869.67%
4,806 $563,000
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $90 - $108
1 Added 0.41%
244 $26,000
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $47,438 - $58,278
-564 Reduced 69.89%
243 $22,000
Q1 2020

Jun 11, 2020

BUY
$72.92 - $121.3 $45,429 - $75,569
623 Added 338.59%
807 $72,000
Q1 2020

May 07, 2020

BUY
$72.92 - $121.3 $13,417 - $22,319
184 New
184 $16.6 Million
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $13,061 - $14,317
-125 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$98.02 - $111.18 $98 - $111
1 Added 0.81%
125 $14,000
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $1,346 - $1,590
-16 Reduced 11.43%
124 $12,000
Q1 2019

May 14, 2019

SELL
$82.45 - $93.79 $164,982 - $187,673
-2,001 Reduced 93.46%
140 $12,000
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $183,697 - $213,008
2,141 New
2,141 $194,000
Q3 2018

Nov 09, 2018

SELL
$85.91 - $99.17 $7,989 - $9,222
-93 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$77.48 - $87.83 $10,149 - $11,505
-131 Reduced 58.48%
93 $8,000
Q1 2018

May 15, 2018

BUY
$76.55 - $87.26 $17,147 - $19,546
224 New
224 $18,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.